30 years of QPS: marking the anniversary with Founder and CEO Benjamin Chien


Contract research organization QPS Holdings, LLC (DE, USA) is celebrating its 30th anniversary in 2025.

Founded in 1995 by Benjamin Chien, QPS has expanded from a single office in Delaware to a global, full-service CRO with eight locations across the United States, Europe, Asia and Australia. Having started from a small molecule shop comprised of 3 people, QPS now boasts 1,200 people on its staff.

“30 years is a major milestone for QPS and I couldn’t be more proud of the hard-working and innovative people who choose to work at QPS. They are the backbone of the company, and I am very grateful for their valuable contributions,” commented Founder and CEO of QPS, Benjamin Chien.

Over the past 30 years, QPS has expanded its service options to include pharmacology, DMPK, toxicology, bioanalysis, translational medicine, leukopaks, PBMCs, cell therapy products and more to provide a full range of clinical research offerings. QPS is known for high-quality data, technical expertise, delivery of promised study timelines, collaborative solutions and customer-focused strategies.


You may also be interested in:


“Through QPS, the pharmaceutical and biotechnology industries have access to dedicated, focused scientific expertise across the drug development spectrum. In facilities around the world, QPS has assembled best-in-class instruments, platforms, people and processes required to conduct the studies necessary to support client drug discovery and development programs focused on obesity, type 2 diabetes, oncology, CNS diseases, cell and gene therapy and more,” explained Benjamin Chien.

Going forward, QPS plans to continue delivering custom-built research services that accelerate pharmaceutical breakthroughs across the globe.

View our collection of resources from QPS Holdings, LLC here.